Key Takeaways
- Pairwise signed a licensing agreement granting Wild Bioscience access to its Fulcrum® genome editing tools.
- Wild Bio will integrate CRISPR-based tools into its AI-driven crop trait development pipeline.
- The collaboration targets resilient crops designed for climate adaptation, yield improvement, and carbon removal.
- The license applies to a range of row crops across Wild Bio’s development programs.
- Fulcrum® includes proprietary gene editing tools, enzymes, and trait libraries for research and commercial use.
Pairwise Grants Wild Bioscience Access to Fulcrum® Platform
Pairwise, an agricultural biotechnology company focused on precision breeding, has announced a licensing agreement with Wild Bioscience Ltd. (Wild Bio). The agreement provides Wild Bio with access to Pairwise’s Fulcrum® genome editing tools for use in crop trait research and commercial development.
Under the terms of the agreement, Wild Bio will incorporate Fulcrum® tools into its research and development pipeline to support the design and development of more resilient crop varieties. The license covers both research and commercial applications across a range of row crops.
Integrating AI-Driven Discovery with CRISPR-Based Editing
Wild Bio applies artificial intelligence and evolutionary biology to identify beneficial plant traits. By combining computational discovery with commercial genetics, the company aims to accelerate crop improvement programs.

4 Comments